Latest Articles
Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: May 21, 2026, 12:46 p.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - Clinical Trials Arena
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial Clinical Trials Arena
Published: May 18, 2026, 4:34 p.m.
Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer - OncLive
Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer OncLive
Published: May 14, 2026, 12:06 a.m.
FGFR2-responsive self-assembled hydrogel releases its inhibitor to suppress the progression of endometriosis.
Fibroblast growth factor receptor 2 (FGFR2) has emerged as a highly promising therapeutic target due to its critical role in the pathogenesis and progression of endometriosis. To date, a variety …
Published: May 9, 2026, midnight
Terazosin as a Non-Hormonal Treatment for Endometriosis.
Endometriosis is a chronic, estrogen-dependent inflammatory disease including aberrant local steroidogenesis, inflammation, angiogenesis, oxidative stress, and prostaglandin-mediated pain. Given the elevated adrenergic receptor expression in endometriotic lesions and the potential …
Published: May 2, 2026, midnight
Endometriosis Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
Endometriosis Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Barchart.com
Published: April 20, 2026, 9:54 p.m.
Endometriosis Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart
Endometriosis Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Barchart
Published: April 20, 2026, 9:54 p.m.
Ascentage Pharma Presents Promising Cancer Research at AACR - The Clinical Trial Vanguard
Ascentage Pharma Presents Promising Cancer Research at AACR The Clinical Trial Vanguard
Published: April 20, 2026, 8 a.m.
SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: April 13, 2026, 12:32 p.m.
SGO 2026 – BioNTech’s Enhertu me-too comes up short | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
SGO 2026 – BioNTech’s Enhertu me-too comes up short | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: April 13, 2026, 10:30 a.m.
Link copied to clipboard!